Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Harvard Bioscience Inc (HBIO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7350
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. Its products are used to advance life science and research, besides drug discovery, and clinical and environmental testing. Harvard Bioscience serves research scientists, hospitals, government laboratories, pharmaceutical and biotechnology companies. The company sells its products through its global sales organization, websites, catalogs and distributors. It has sales and manufacturing operations in the US, the UK, Germany, Sweden, Spain, France, Canada and China. Harvard Bioscience is headquartered in Holliston, Massachusetts, the US.

Harvard Bioscience Inc (HBIO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Harvard Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Harvard Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Harvard Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Harvard Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Harvard Bioscience Inc, Medical Equipment, Deal Details 10
Partnerships 10
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Equity Offering 12
Harvard Bioscience Plans to Raise up to USD50 Million in Public Offering of Securities 12
Acquisition 13
Thomas Scientific Acquires Denville Scientific from Harvard Bioscience for USD20 Million 13
Harvard Bioscience Sells AHN Biotechnologie for USD1.7 Million 15
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience Inc – Key Competitors 19
Harvard Bioscience Inc – Key Employees 20
Harvard Bioscience Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 23
Financial Announcements 23
Jul 26, 2018: Harvard Bioscience Reports Second Quarter 2018 Financial Results 23
May 02, 2018: Harvard Bioscience Reports First Quarter 2018 Financial Results 25
Oct 26, 2017: Harvard Bioscience Reports Third Quarter 2017 Financial Results 26
Jul 27, 2017: Harvard Bioscience Reports Second Quarter 2017 Financial Results 28
Apr 27, 2017: Harvard Bioscience Reports First Quarter 2017 Financial Results 29
Mar 09, 2017: Harvard Bioscience Reports Fourth Quarter and Year-End 2016 Results and 2017 Financial Guidance 30
Corporate Communications 32
Aug 22, 2018: Harvard Bioscience announces management change 32
Oct 25, 2017: Harvard Bioscience Appoints Katherine Eade and Thomas Loewald to the Board of Directors 33
Jun 07, 2017: Harvard Bioscience Elects James Green as Chairman of Board of Directors 34
Product News 35
Jun 13, 2018: Harvard Bioscience Subsidiary Data Sciences International Launches Inhalation Exposure System 35
May 01, 2018: Harvard Bioscience Subsidiary Multi Channel Systems Launches Beta Cell Screening System for Diabetes Research, Entering New Segment of Electrophysiology Market 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Harvard Bioscience Inc, Medical Equipment, Key Facts, 2017 2
Harvard Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Harvard Bioscience Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Harvard Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Harvard Bioscience Inc, Deals By Market, 2012 to YTD 2018 8
Harvard Bioscience Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Fluxion Biosciences Enters into Distribution Agreement with Harvard Bioscience 10
Biochrom Enters into Co-Marketing Agreement with Gilson For Automated ELISA 11
Harvard Bioscience Plans to Raise up to USD50 Million in Public Offering of Securities 12
Thomas Scientific Acquires Denville Scientific from Harvard Bioscience for USD20 Million 13
Harvard Bioscience Sells AHN Biotechnologie for USD1.7 Million 15
Harvard Bioscience Acquires Multi Channel Systems 16
Harvard Bioscience Acquires Triangle BioSystems 17
Harvard Bioscience Acquires AHN Biotechnologie, Maker Of Plastic Consumable Lab Products, For US$2.6 Million 18
Harvard Bioscience Inc, Key Competitors 19
Harvard Bioscience Inc, Key Employees 20
Harvard Bioscience Inc, Subsidiaries 21

List of Figures
Harvard Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Harvard Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Harvard Bioscience Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Harvard Bioscience Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Harvard Bioscience Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Harvard Bioscience Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Harvard Bioscience Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Glidewell Laboratories:企業の戦略的SWOT分析
    Glidewell Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Endurance International Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    Endurance International Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endurance International Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Jackson Electric Membership Corporation:企業の戦略的SWOT分析
    Jackson Electric Membership Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • ICA Gruppen AB:企業の戦略・SWOT・財務情報
    ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report Summary ICA Gruppen AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Castle Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Castle Biosciences Inc (Castle Biosciences) is a drug development company that develops and commercializes diagnostic and prognostic tests for cancers. The company offers tests for cutaneous melanoma, uveal melanoma and glioblastoma multiforme. Its DecisionDx-melanoma identifies stage I or I …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Open Text Corporation (OTEX):企業の財務・戦略的SWOT分析
    Open Text Corporation (OTEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Seair Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Seair Inc, doing business as Dover Water Solutions, is a clean technology company that carries out research and development, production and sale of gas diffusion technologies. It focuses on commercializing advanced waste water and industrial fluid treatment solutions. The company offers high …
  • Valeritas Inc:医療機器:M&Aディール及び事業提携情報
    Summary Valeritas Inc (Valeritas) is a medical technology company that develops and commercializes treatment solutions for diabetes. The company’s product includes V-Go insulin delivery device a wearable basal-bolus insulin delivery solution for patients with Type 2 diabetes. It also provides V-Go l …
  • Foodwell Corporation:企業の戦略・SWOT・財務分析
    Foodwell Corporation - Strategy, SWOT and Corporate Finance Report Summary Foodwell Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Knight Therapeutics Inc (GUD):企業の財務・戦略的SWOT分析
    Summary Knight Therapeutics Inc (Knight Therapeutics) is a specialty pharmaceutical company focused on acquisition, licensing, marketing and distribution of prescription, consumer health products and medical devices. Its consumer health products are used for the treatment of metabolic diseases, derm …
  • SAES Getters S.p.A. (SG):企業の財務・戦略的SWOT分析
    SAES Getters S.p.A. (SG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • QAD Inc (QADA):企業の財務・戦略的SWOT分析
    QAD Inc (QADA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Theratechnologies Inc (TH):製薬・医療:M&Aディール及び事業提携情報
    Summary Theratechnologies Inc (Theratechnologies) is a pharmaceutical company that focuses on the discovery and development of drugs for metabolic disorders. The company develops therapeutic peptide products, with an emphasis on growth releasing factor (GRF) peptides. Its lead products include Egrif …
  • Meridian Energy Limited:企業の戦略・SWOT・財務分析
    Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Meridian Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • SOGAZ Insurance Group:企業の戦略・SWOT・財務分析
    SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report Summary SOGAZ Insurance Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • R. R. Donnelley & Sons Co (RRD):企業の財務・戦略的SWOT分析
    R. R. Donnelley & Sons Co (RRD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Banca Transilvania S.A.:企業の戦略・SWOT・財務情報
    Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report Summary Banca Transilvania S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆